(S (NP (NP (NP (DT The) (NN occurrence)) (PP (IN of) (NP (NN drug) (HYPH -) (NN drug) (HYPH -) (NNS interactions))) (PRN (-LRB- -LRB-) (NP (NNP DDI)) (-RRB- -RRB-))) (PP (IN from) (NP (JJ multiple) (NN drug) (NNS dispensations)))) (VP (VBZ is) (NP (NP (DT a) (JJ serious) (NN problem)) (, ,) (CC both) (PP (IN for) (NP (NP (NML (NML (NNS individuals)) (CC and) (NML (NN health) (HYPH -) (NN care))) (NNS systems)) (, ,) (SBAR (IN since) (S (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS complications)) (PP (IN due) (PP (IN to) (NP (NNP DDI))))))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB reenter) (NP (DT the) (NN system))))))))))) (PP (IN at) (NP (DT a) (ADJP (JJR costlier)) (NN level))))) (. .))
(S (NP (PRP We)) (VP (VBP present) (NP (NP (DT a) (NML (JJ large) (HYPH -) (NN scale)) (JJ longitudinal) (NN study) (PRN (-LRB- -LRB-) (NP (CD 18) (NNS months)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NNP DDI) (NN phenomenon)))) (PP (IN at) (NP (NP (DT the) (NML (ADJP (JJ primary) (HYPH -) (CC and) (JJ secondary)) (HYPH -) (NN care)) (NN level)) (VP (VBG using) (NP (NP (NML (JJ electronic) (NN health)) (NNS records) (PRN (-LRB- -LRB-) (NP (NNP EHR)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (DT the) (NN city)) (PP (IN of) (NP (NNP Blumenau)))))) (PP (IN in) (NP (NP (NNP Southern) (NNP Brazil)) (-LRB- -LRB-) (NP (NN pop)))))))) (. .))
(S (ADVP (RB Interestingly)) (, ,) (NP (DT a) (JJ statistical) (JJ null) (NN model)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (ADJP (NP (NP (NN age)) (HYPH -) (CC and) (NP (JJ female))) (HYPH -) (JJ specific)) (NNS risks)) (PP (IN from) (NP (VBN increased) (NN polypharmacy)))) (VP (VBP fail) (PP (IN by) (ADVP (RB far))) (S (VP (TO to) (VP (VB explain) (NP (NP (DT the) (VBN observed) (NNP DDI) (NNS risks)) (PP (IN in) (NP (DT those) (NNS populations))))))) (, ,) (S (VP (VBG suggesting) (NP (JJ unknown) (ADJP (JJ social) (CC or) (JJ biological)) (NNS causes)))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP provide) (NP (NP (DT a) (NN network) (NN visualization)) (PP (IN of) (NP (NP (NNS drugs)) (CC and) (NP (NP (JJ demographic) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP characterize) (NP (DT the) (NNP DDI) (NN phenomenon))) (CC and) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (JJ accurate) (NNP DDI) (NN prediction)) (VP (MD can) (VP (VB be) (VP (VBN included) (PP (IN in) (NP (NML (NML (NN healthcare)) (CC and) (NML (JJ public) (HYPH -) (NN health))) (NN management))) (, ,) (S (VP (TO to) (VP (VB reduce) (NP (NP (ADJP (NNP DDI) (HYPH -) (VBN related)) (NN ADR)) (CC and) (NP (NNS costs)))))))))))))))))))) (. .))
